Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

In vitro metabolism of LDL labeled with a nondegradable cholesteryl ester analogue

Journal Article · · Arteriosclerosis (Dallas); (United States)
Low density lipoprotein (LDL) metabolism by human skin fibroblasts was studied using LDL labeled in the neutral lipid fraction with a nonhydrolysable cholesteryl ester analogue /sup 3/H-cholesteryl linoleyl ether (/sup 3/H-CLE-LDL). LDL uptake could be quantitated accurately using /sup 3/H-CLE-LDL, since the label accumulated intracellularly due to its resistance to hydrolysis. /sup 3/H-CLE-LDL was taken up via apo B,E receptor-mediated endocytosis in a manner similar to /sup 125/I-labeled LDL. This was demonstrated by similar rates of uptake of the two differently labeled LDL preparations, saturation kinetics of uptake with respect to /sup 3/H-CLE-LDL concentration, regulation of /sup 3/H-CLE-LDL uptake by procedures that up-regulate or down-regulate the number of apo B,E receptors, and negligible uptake of /sup 3/H-CLE-LDL by receptor-negative cell strains. The major difference between the handling of /sup 125/I-LDL and /sup 3/H-CLE-LDL was the finding that, while the amount of trypsin-releasable (surface) /sup 3/H-CLE increased progressively over a 24-hour experimental period, trypsin-releasable /sup 125/I-LDL reached a maximum within 30 minutes. After 24 hours of incubation, the /sup 3/H radioactivity released by brief trypsinization was three to four times higher than could be accounted for by /sup 125/I radioactivity released by a similar treatment. Possible reasons for this behavior are discussed.
Research Organization:
UCT/MRC Muscle Research Unit, UCT Medical School, South Africa
OSTI ID:
7008012
Journal Information:
Arteriosclerosis (Dallas); (United States), Journal Name: Arteriosclerosis (Dallas); (United States) Vol. 4:3; ISSN ARTRD
Country of Publication:
United States
Language:
English